6 patienk with Heiner's Syndrome were found by screening for multiple precipitins in 160consecutive childrenwith idiopathic chronic lungdisease.
All 6 were black; 3 were infants and 3 were 1-4 yeanof age. All had normal or elevated serum immunoglobulins, normal sweat chlorides, and AA orAS hemoglobin. None were clearly predisposed toaspiration. All displayed typical manifestations of Heiner's Syndrome; recurrent pulmonary infiltrates (6/6), hemosiderin-laden macrophages (5/6), intermittentwheezing (4/6), eosinophilia (4/6), irondeficiency (4/6), and failure to thrive (4/6).
The 3older patientsalso manifestedchronicrhinitis, large adenoids, evidenceof right heart failure, hypercapniaand acidosisduringsleep, and pulmonary/systemic resistance ratios of 1/2 to 1/3 with resultant mean pulmonary artery pressures from 35-45 mmHg . Symptomatic theropy, a cow's milkfreediet, andadenoidectomywhen indicated led to improvement in all patients . Heiner's Syndrome and upperairway obstruction wi th pulmonary hypertension may be twostages, early and delayed, of the same process. Early dietary intervention may prevent cardiac complications and C 0 2 narcosis in children with this process. I n 3 i n f a n t s (birthweight 920,1720 and 20?0 g) with c l i n i c a l and radiologic BPD, minute volume WE), lung compliance CL (ml/cm ~~O / k g ) , pulmonary r e s i s t a n c e RL (cm H20/ L/sec) and blood gases were measured repeatedly during t h e f i r s t eight weeks of l i f e . A l l had severe respiratory dist r e s s syndrome a t b i r t h and they were t r e a t e d with high 02 and a s s i s t e d v e n t i l a t i o n f o r varying periods of time. Two inf a n t s remained 02 dependent u n t i l death a t 4 and 11 wks. of age, and t h e survivor u n t i l 4 months of age. The mean of t h e measurements i n each i n f a n t was s i g n i f i c a n t l y below normal f o r CLlkg, 0.3, 0.4, and 1.1 respectively and s i g n i f i c a n t l y increased f o r RL a t mid-inspiration 107, 81 and 52, a t midexpiration 190, 218, 247, and mean RL 143, 158, 109 respectively. CE was increased (720 mlfmin). A r t e r i a l blood gases showed hypoxia and hypercarbia r e f l e c t i n g t h e i n f a n t s ' c l i n i c a l condition. A l a r g e portion of t h e abnormalities could be explained by an extreme l o s s of lung volume (atelect a s i s ) and lung f i b r o s i s . This was confirmed by necropsy i n 2 cases. The two most severely ill i n f a n t s had p e r s i s t e n t l y low lung compliance and succumbed due t o i n t r a c t a b l e lung damage.
EARLY PULMONARY FUNCTION STUDIES OF INFANTS

THE CONTROL OF RESPIRATORY FREQUENCY I N PREMATURE INFANTS.
M.H. Bryan, A.C. Bryan. Dept. of P e d i a t r i c s , Univ. of Toronto and the Research I n s t . , The Hosp. f o r Sick Children, Toronto, Canada ( I n t r . by P.R. Swyer).
There a r e two components t o respiratory frequency i n the premature i n f a n t : a phasic component r e l a t e d t o the Hering Breuer r e f l e x and a tonic component s e t by the bulbo-pontine centres. W e have previously shown t h a t the phasic component is r e l a t e d t o g e s t a t i o n a l age.* W e have now attempted t o quan t i t a t e t h e bulbo-pontine output by measuring the inspiratory duration and pressure developed during airway occlusion a t FRC. W e have studied 10 i n f a n t s under 1400g., a l l with peri o d i c breathing, and correlated t h e r e s u l t s with t h e blood gases. There i s a s i g n i f i c a n t (p<0.01) c o r r e l a t i o n between i n s p i r a t o r y duration (l/Tiocc) and the r a t e of change of pressure (dP/dt) with pC02 (1/TioCc = 0.09 pC02 -1.66). There i s no c o r r e l a t i o n with the p02. These r e s u l t s suggest t h a t the bulbo-pontine output is primarily determined by pCO2. However, because inspiratory duration becomes so s h o r t , the maximum pressure developed f a l l s with r i s i n g pC02. This makes t h e r e s p i r a t o r y system very vulnerable t o respiratory loads. This v u l n e r a b i l i t y i s l o s t i n older premature i n f a n t s a s they develop l a r g e pressures when breathing against an obstruction.
DEVELOPMENT OF A PRACTICAL DISPOSABIE CPAP HEAD BAG, Paul A. A p r a c t i c a l disposable head bag has been developed f o r delivering Continuous Positive Airway Pressure (CPAP), obviating the need f o r the i n s e r t i o n of an endotracheal tube or a nasal piece.
The head bag i t s e l f i s made of transparent polyvinyl chloride f i l m allowing v i s u a l i z a t i o n of the face and head of the infant. A vinyl press -closure zipper i s incorporated i n the head bag so t h a t with a simple separation of the zip lock, access t o the nose and mouth f o r suctioning i s possible.
Air-oxygen mixture then passes t o the head compartment. The pressure throughout the system, both i n the neck c o l l a r and i n the head bag, a r e e s s e n t i a l l y the same.
15 i n f a n t s have been treated. 3 i n f a n t s developed a pneumothorax.
3 a r e considered f a i l u r e s because i t was necessary t o intubate and v e n t i l a t e these infants.
2 i n f a n t s developed a macular papular rash on t h e neck resembling erythema toxicum. Smear demonstrated eosinophilia and b a c t e r i a l c u l t u r e was negative.
OUTPUT OF THE FETAL RESPIRATORY CENTRE IN-UTERO. Victor
Chernick and Andrija Bahoric. Dept. Pediat., Univ. of Manitoba, Winnipeg, Canada.
Dawes, using i n d i r e c t methods described t h e presence of f e t a l respiratory movements up t o 40% of the time with a frequency of 1 t o 4 Hz. W e undertook t o monitor f e t a l respiratory centre output in-utero more d i r e c t l y by simultaneous recording of t r a c h e a l pressure & phrenic & diaphragmatic e l e c t r i c a l a c t i v i t y i n awake sheep. One week was allowed f o r recovery following surgery. Four f e t u s e s were studied from 132 days t o 145 days gestation and a t o t a l of 29.4 hours of recording analyzed i n d e t a i l . Phrenic nerve a c t i v i t y was found i n a l l fetuses and was coupled with diaphragmatic a c t i v i t y and t r a c h e a l pressure changes. I n c o n t r a s t t o newborn and adult animals, f e t a l phrenic nerve a c t i v i t y was not phasic but consisted of episodic b u r s t s interspersed by quiescent periods l a s t i n g up t o 30 minutes. There were two types of b u r s t s : a) a s h o r t b r i e f b u r s t with an average duration of 267 msec, b) a more prolonged burst with an average duration of 1.9 sec. Type A burst occurred 1313 times and type B 462 times during 29.4 hours; thus f e t a l respirat i o n occurred during a t o t a l of 20.3 minutes or approximately 1% of the time. Continuous r e s p i r a t i o n was seen on 2 occasions j u s t p r i o r t o f e t a l death. These s t u d i e s i n d i c a t e t h a t normally the f e t a l respiratory centre during l a t e f e t a l l i f e i s only minimally a c t i v e in-utero. Continuous i n t r a u t e r i n e r e s p i r a t i o n i s probably associated with f e t a l asphyxia. Supported by M R C (Canada) h Children's Hospital Research Pdn. Each d.y t h e i r p u e n t s completed data sheets assessing t h e i r symptoms and other msdicatians. Each math they w r e exined by their a l l e r g i s t and provided with nmf sheets and msdicatiarr. Duratim o f the study WM 5 maths. lbere w r e no significant differences i n the 2 groups a t the outsot, but by the s e c a d math the pyridoxbu group had significantly (p < 0.02) h a s 8 6 -a t h c b s . and a brmchodilrtor Wdicine was being used. Significant differences i n wheezing, tightness i n chest, breathing d i f f i c u l t y and cough medicine w m r l s o s e a . W e had previously reported (SPR, 1972) significant abnormrllty i n e x c r e t i a of x a n t h w n i c and kynurenic acid before and after oral tryptophaaa loading which returned toward normal v i t h oral pyridoxine therapy. Those and other studies suggest that asthmatic children ham a relative increase i n serotcnin and dsclrsae i n epinephrine productiarr which are a t lorat partially remrsibla with pyridoxine therrPY e
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